NMN vs. NR: What the Longevity Headlines Won't Tell You About the Two Most Hyped Anti-Aging Supplements

BEYOND THE HEADLINES

Bio Precision Aging — Member Deep Dive Series  | August 5 ,2026

You have seen the headlines. “The molecule that could reverse aging.” “The supplement Silicon Valley billionaires take every morning.” “Scientists discover the fountain of youth in a pill.” Type “NAD+” into a search bar and you will drown in miracle claims, glossy influencer ads, and $90 bottles promising to turn back your biological clock. Two names keep surfacing above the noise — NMN and NR — usually pitched as rivals, with each brand insisting theirs is the superior one.

Here is what those headlines rarely mention: most of them are built on studies done in mice, not people. And the ones done in people are smaller, quieter, and far more honest about what we actually know. The truth is more interesting than the hype — and more useful, because it can actually help you decide whether either of these is worth your money.

This article goes past the marketing. We walk through every human trial that matters — what it found, what it didn't, and what it means for you — so you can make a decision based on evidence instead of enthusiasm.

First, What Is This NAD+ Everyone's Selling?

Think of NAD+ (nicotinamide adenine dinucleotide) as one of the most important helper molecules your cells run on. It is the fuel that powers a family of “repair and maintenance” proteins. Two of them matter most here. The sirtuins are like your cells’ quality-control crew — they tune which genes switch on, keep your mitochondria (the tiny power plants inside every cell) healthy, and manage how cells respond to stress. And PARP1 is your genome’s emergency repair technician, patching breaks in your DNA before they cause trouble. Both of these run on NAD+. No NAD+, no repair.

Here is the catch, and it is the real reason anyone cares about this topic: your NAD+ levels fall as you age. Studies estimate a 40–60% drop between age 20 and age 60, and the decline is steepest in the tissues you least want it in — muscle and brain. Less NAD+ means your repair crews are understaffed, which scientists have tied directly to the classic signs of aging: sluggish mitochondria, mounting DNA damage, and a metabolism that no longer behaves the way it did in your twenties [1][2].

So the logic behind the whole industry is simple and, on its face, reasonable: if aging drains your NAD+, maybe topping it back up helps. You cannot just swallow NAD+ directly — it is too bulky to get into cells efficiently — so supplement makers sell the raw materials your body uses to build it. The two front-runners are nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are close cousins of vitamin B3, and both have now been tested in real human trials. That last part is what separates this topic from the rest of the supplement aisle.

The NMN-vs-NR Feud &

The 2026 Study That Settled It

For years the marketing has run on a tidy story. NR gets absorbed and then your body adds a chemical tag (a phosphate) to convert it into NMN, which becomes NAD+. NMN, the pitch goes, skips a step — so it should be the more “direct,” more powerful option. It sounds convincing. It also appears to be mostly wrong.

In early 2026, researchers led by Christen and colleagues ran the study everyone had been waiting for and published it in Nature Metabolism: the first head-to-head human comparison of NMN, NR, and plain nicotinamide, in 65 healthy adults over 14 days [3]. The headline finding is refreshingly clear. NR and NMN raised blood NAD+ by roughly the same amount — about double — while plain nicotinamide didn’t hold that elevation. In other words, the two premium products people argue about performed essentially the same.

The why is the fun part, and it upends the “NMN skips a step” story entirely. The researchers found that both NMN and NR appear to lean heavily on your gut bacteria, which convert them into nicotinic acid (another B3 form) that your body then uses to build NAD+ through a different route entirely. Their evidence even suggests NMN is largely broken down back into NR in your gut before it is absorbed — so the “shortcut” may not exist in practice. One likely upshot: because so much depends on your personal microbiome, how well you respond may vary from the next person, which could explain why some people swear by these supplements and others feel nothing.

Bottom line on the great debate: for the one thing both are sold to do — raise your NAD+ — NMN and NR are a tie. Anyone charging a premium because one is “biochemically superior” is selling you a story the best human data doesn’t support.

What NAD+ Actually Does Once It's Back Up

It helps to know what you are paying for at the cellular level. There are four main jobs NAD+ enables, and they map neatly onto why researchers think it might matter for aging.

1. It powers the sirtuins — your cellular quality-control crew

The sirtuins (there are seven, SIRT1 through SIRT7) are switches that need NAD+ to work. SIRT1 manages cellular “housekeeping” (clearing out damaged parts), keeps inflammation in check, and helps run your body clock. SIRT3 protects the mitochondria. When NAD+ runs low, these switches stall — and stalled sirtuins are a big part of why aged tissue behaves the way it does [1][2].

2. It refuels DNA repair — and breaks a vicious cycle

Here is a detail that makes the aging story click. When your DNA gets damaged — and it does so more with age — the repair technician PARP1 rushes in and burns through NAD+ to fix it. Under heavy stress, PARP1 can consume up to 80% of a cell’s nuclear NAD+, leaving the sirtuins starved. That kicks off a downward spiral: more damage → more PARP1 activity → less NAD+ → worse repair → even more damage. The appeal of topping up NAD+ is that it may break this loop before it snowballs [2].

3. It helps build new mitochondria

SIRT1 flips on a master switch called PGC-1α that tells cells to manufacture new power plants. Restore NAD+ and you re-engage that switch, which should mean more mitochondria and more efficient energy production. This is exactly the machinery that falters in age-related muscle loss and metabolic disease — which is why so much of the research points at those conditions [1][4].

4. It calms inflammation

Higher NAD+ quiets NF-κB, one of the body’s main inflammation signals, again by way of SIRT1. In a 2026 trial in people with psoriasis, NR dialed down the overactive immune response driving the disease through a specific signaling pathway (SLIT2/ROBO1) [9]. It is early, but it hints at a broader anti-inflammatory role — relevant to what scientists call “inflammaging,” the slow-burn inflammation that accompanies getting older.

The Research: Seven Human Trials, Read Honestly

This is where the headlines and the reality part ways. The evidence is real, but it is a story of promising signals rather than slam-dunk cures. Here is each human trial that matters, in plain terms — the good and the disappointing alike.

Yoshino et al., 2021 — NMN and blood sugar

A rigorous 10-week trial (randomized, placebo-controlled, double-blind — the gold standard) gave 250 mg/day of NMN to 25 postmenopausal women with prediabetes who were overweight or obese [1]. The result made news for good reason: NMN meaningfully improved how well the women’s muscle responded to insulin, along with genetic signs of muscle remodeling. It was the first human trial to show NMN doing something concrete and tissue-specific, not just nudging a number on a lab report. The caveat worth remembering: 25 people is small.

Igarashi et al., 2022 — NMN in healthy older men

A 12-week gold-standard trial gave 250 mg/day of NMN to healthy older men [4]. Blood tests confirmed NAD+ climbed as expected, and there were modest improvements in walking speed and grip strength, with no side effects. Encouraging — but be honest about the fine print: those functional gains were only “nominally” significant, meaning they cleared the bar just barely and could shrink or vanish in a bigger study. It is a hint, not a headline.

Christen et al., 2026 — the head-to-head

We covered this one above, and it is the single most important study in the field. Comparing NMN, NR, and nicotinamide in 65 adults, it found NMN and NR raise NAD+ about equally (roughly double), both apparently relying on your gut bacteria to do it [3]. If you read only one study on this topic, make it this one — it is the reason the “which is better” debate is mostly marketing.

Wu et al., 2025 — NR for long-COVID

This is the disappointing one, and it deserves your attention precisely because the marketing will never mention it. A solid 24-week trial at Massachusetts General Hospital gave a hefty 2000 mg/day of NR to 58 adults with long-COVID [5]. The supplement absolutely worked at the biochemical level — NAD+ shot up 2.6 to 3.1 times over. But on the outcomes people actually care about — brain fog, fatigue, sleep, mood — there was no meaningful difference from placebo in the main analysis. Digging afterward hinted at some late improvement in focus and energy, but those were exploratory fishing expeditions, not proof. The lesson is the theme of this whole article: raising NAD+ is easy; turning that into how you feel is the hard, unsolved part.

Wu et al., 2025 — NR and an Alzheimer's marker

A cleverly designed crossover trial gave 1 g/day of NR for 8 weeks to 46 adults over 55 with early memory concerns [6]. The intriguing result: a blood marker of early Alzheimer’s damage called pTau-217 dropped 7% on NR while rising 18% on placebo — a real, statistically significant gap. pTau-217 is one of the most sensitive early warning signals we have for Alzheimer’s. Now the sober part: memory and thinking test scores didn’t actually improve, almost certainly because 8 weeks is far too short to move them. A moved biomarker is a genuinely promising lead. It is not yet evidence that NR slows dementia — that requires longer, larger trials.

Shoji et al., 2025 — NR in Werner syndrome

This may be the most striking human result of the bunch. Werner syndrome is a rare genetic disease that makes people age dramatically fast — essentially a living, accelerated model of aging. A 26-week gold-standard trial gave these patients 1000 mg/day of NR [8]. The outcomes were concrete: stiff arteries loosened up (a measured improvement in arterial stiffness), stubborn skin ulcers shrank, and a kidney marker improved — all with no serious side effects. This is the closest thing we have to direct human proof that topping up NAD+ can actually push back on aging at the tissue level. The honest caveat: it is a rare disease, and what helps fast-aging patients may not translate cleanly to ordinary aging.

Lin et al., 2025 — NR plus exercise for blood pressure

A small pilot put 54 sedentary adults 55 and older with elevated blood pressure into groups: NR plus exercise, placebo plus exercise, or NR alone, for 6 weeks [7]. The main goal — lowering top-number blood pressure more than exercise alone — was not met. There were faint hints that NR-plus-exercise did a bit more for artery flexibility and nighttime blood pressure in people not already on medication. Interesting as a “maybe NR makes exercise work better” hypothesis, but this is a small pilot, and “trends” are not results. It needs a real, larger trial before anyone should bank on it.

So Should You Take It? Here's Our Honest Read

After walking through all of it, here is a point of view grounded in what the studies actually show — not what the ads promise. NMN and NR are among the few supplements in the entire longevity aisle with real human trials behind them, and they reliably do the one biochemical thing they claim: they raise your NAD+. That alone puts them a cut above most of what gets marketed as anti-aging. But raising NAD+ is the easy part. Whether that translates into a longer, healthier life is still genuinely unproven, and anyone who tells you otherwise is ahead of the evidence.

That said, the case is strongest for specific people, not everyone. If you see yourself below, there is a real, evidence-based rationale to consider a trial — with your doctor — rather than just hope.

• Adults 50+ with metabolic issues — prediabetes, insulin resistance, metabolic syndrome. NMN has the most direct evidence here, for improving how muscle handles blood sugar [1].

• People with unexplained fatigue or known mitochondrial problems — restoring NAD+ re-engages the machinery that builds and maintains your cellular power plants [2].

• Adults with early memory concerns who want to act at the biomarker stage — NR’s effect on pTau-217 is worth a conversation with your physician [6].

• People with stiffening arteries — the strongest tissue-level evidence comes from the accelerated-aging (Werner syndrome) trial [8].

• Sedentary people trying to get more out of starting an exercise program — the NR-plus-exercise signal is suggestive, if unproven [7].

• If you do try it, don’t fly blind — measure. The point of monitoring is to see whether you are actually one of the responders. A sensible plan your doctor can order: fasting glucose and insulin (a HOMA-IR score) at the start, 8 weeks, and 16 weeks; a full metabolic panel including kidney and liver markers; optional pTau-217 if memory is your concern; blood pressure and arterial-stiffness measures if your worry is cardiovascular; and honest tracking of your own energy, sleep, and exercise tolerance. If nothing budges after a fair trial, that is useful information too.

If You Decide to Try It: Sensible Dosing

These ranges come straight from the human trials above, not from label hype.

• NMN: 250–900 mg/day. Most of the positive metabolic data used just 250 mg/day [1][4]. Higher doses (600–900 mg) push NAD+ up more, but that extra elevation didn’t buy extra benefit in the main analyses — so more isn’t clearly better.

• NR: 500–2000 mg/day. The cognitive and inflammation studies leaned on 1000–2000 mg/day [5][6]; the standout Werner syndrome trial used 1000 mg/day with excellent tolerability [8].

• A reasonable starting point for general use (adults 50+): 500 mg/day of either NMN or NR — a dose with solid safety data behind it.

Timing: morning, with food. NAD+ helps run your body clock through SIRT1, and morning dosing lines up with your natural daily NAD+ peak. Duration: give it a fair shot — at least 12 weeks before you judge it. NAD+ rises within about 2 weeks and stays up with daily use, but the downstream effects, if they come, take longer to show.

Is It Safe? Mostly Yes — With a Few Real Cautions

Across every human trial reviewed here, NMN and NR were well tolerated over the short term — up to 2000 mg/day of NR and 900 mg/day of NMN — with no serious side effects pinned on either. The most common complaint is mild, temporary stomach upset (nausea or loose stools) in a minority of people, and it tends to track with higher doses.

But “well tolerated in trials” is not the same as “fine for everyone,” and a few cautions are worth taking seriously. If you are on cancer treatment — specifically PARP-inhibitor drugs like olaparib or rucaparib — there is a theoretical worry that boosting NAD+ could work against the drug, since those medicines are designed to starve cancer cells of exactly this repair pathway. Until we know more, avoid combining them. If you take insulin or other glucose-lowering medication, monitor your blood sugar closely, because NMN can improve insulin sensitivity and shift your numbers. There are no absolute deal-breakers identified in the human data, but active cancer (that PARP concern) and pregnancy or breastfeeding (simply untested) are sensible reasons to hold off. As always, loop in your doctor before starting.

The Bottom Line

Strip away the marketing and here is what remains, which is plenty. Both NMN and NR reliably raise your body’s NAD+ — that much is settled, confirmed in every trial. The 2026 head-to-head showed they do it about equally well, most likely because both depend on your gut bacteria to get the job done [3]. So the choice between them should come down to cost, how your body tolerates each, and your specific health goal — not to which brand shouts loudest about being “superior.”

The real, unresolved question — the gap the headlines paper over — is whether reliably raising NAD+ actually delivers a longer, healthier life. We have genuinely encouraging signals: better insulin response with NMN [1], a moved Alzheimer’s biomarker with NR [6], and real tissue-level improvements in a human accelerated-aging model [8]. Those are meaningful. They are not yet proof that these supplements extend healthy lifespan or prevent any specific disease. The mechanism is compelling; the long-term human payoff is still being written.

Ouir take: this is one of the more scientifically credible bets in the longevity aisle — which is a real compliment given how much junk is on that shelf. It is best used with intention: targeted at higher-risk people (adults 50+ with metabolic, cognitive, or cardiovascular concerns), monitored with actual bloodwork so you know if you’re responding, and revisited as the bigger trials report over the next 3–5 years. Not a miracle. Not snake oil. A reasonable, evidence-backed experiment — run it on yourself with your eyes open.

References

[1] Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. PMID: 33888596. https://pubmed.ncbi.nlm.nih.gov/33888596/

[2] Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17(11):679-690. PMID: 27552971. https://pubmed.ncbi.nlm.nih.gov/27552971/

[3] Christen S, et al. The differential impact of three different NAD+ boosters on circulatory NAD+ and microbial metabolism in humans. Nat Metab. 2026;8(1):62-73. PMID: 41540253. https://pubmed.ncbi.nlm.nih.gov/41540253/

[4] Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels and alters muscle function in healthy older men. npj Aging. 2022;8(1):5. PMID: 35927255. https://pubmed.ncbi.nlm.nih.gov/35927255/

[5] Wu CY, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID. EClinicalMedicine. 2025;89:103633. PMID: 41357333. https://pubmed.ncbi.nlm.nih.gov/41357333/

[6] Wu CY, et al. Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside supplementation in older adults with SCD and MCI. Alzheimers Dement (N Y). 2025;11(1):e70023. PMID: 39817194. https://pubmed.ncbi.nlm.nih.gov/39817194/

[7] Lin Y, et al. Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults. GeroScience. 2025;47(6):6895-6908. PMID: 40770531. https://pubmed.ncbi.nlm.nih.gov/40770531/

[8] Shoji M, et al. Nicotinamide riboside supplementation benefits in patients with Werner syndrome. Aging Cell. 2025;24(8):e70093. PMID: 40459998. https://pubmed.ncbi.nlm.nih.gov/40459998/

[9] Han K, et al. NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis. JCI Insight. 2026;11(12). PMID: 42048163. https://pubmed.ncbi.nlm.nih.gov/42048163/

DISCLAIMER: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified physician before starting any new supplement or health protocol. Individual results vary.